Categories: All postsAnalysts

Celestica downgraded to “Hold” at Beacon Securities

Following a sharp upward surge in its share price that began in April, Beacon Securities analyst Gabriel Leung has downgraded Celestica (TSX:CLS) on valuation concerns.

On Tuesday, July 31, after the market close, Celestica will report its Q2, 2018 results. Leung expects the company will post Adjusted EPS of $0.26 on revenue of $1.57-billion, a little below the street consensus of earnings of $0.28 on a topline of $1.61-billion.

In a research update to clients today, Leung downgraded Celestica from “Buy” to “Hold” while mainained his target price of (US) $13.00, which implied a return of seven per cent at the time of publication.

The analyst explained his reasoning.

“We are downgrading Celestica to Hold from Buy largely based on valuation. Our $13.00 target price, which is based on 6x CY18e EV/EBITDA remains unchanged and represents a 7% potential return,” Leung noted. “Valuation-wise, Celestica is trading at ~6x current year EV/EBITDA versus the group at ~7x. If we exclude outliers, then we Celestica is trading in-line with the group average of ~6x.”

Leung thinks Celestica will generate EBITDA of $281-million on revenue of $6.24-billion in fiscal 2018.

The analyst says margins, which are always a hot topic around CLS, may be facing some new pressure.

“(Celestica) guided for H2 2018 operating margins to improve to the 3.5% range (Q1 was ~3%) so we will see if that guidance remains intact,” Leung said. “While the company has been managing expenses through restructuring initiatives, it also did highlight pricing pressure and component shortages, which could limit the extent of near-term margin improvements.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cls
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

4 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

4 days ago